Veradermics

Today we are proud to share that our lead investigational product, VDPHL01, is currently in a Phase 2/3 registration-directed clinical trial for female pattern hair loss, marking the first Phase 3 trial in women for an oral treatment.    An estimated 30 million women are affected by pattern hair loss in the U.S. and despite its prevalence, there is still no FDA-approved oral treatment for pattern hair loss in women.    We are committed to filling this gap, and excited about VDPHL01’s potential to transform the treatment landscape for women.     Learn more: bit.ly/3JJDWK6    #femalepatternhairloss #androgeneticalopecia #hairloss #innovation #clinicaltrials 

Veradermics is growing, and we’re looking for a detail-oriented, proactive Medical Affairs Engagement Coordinator to help drive our scientific engagement efforts. In this role, you’ll: 🔹 Coordinate adisory boards, KOL engagement & medical events 🔹 Manage contracts, POs, vendors & budget tracking 🔹 Support strategic communication and collaboration across Medical Affairs, Clinical, and Operations teams  This is a great fit for someone who: ✔ Has experience in medical affairs, scientific ops, or event/logistics roles ✔ Loves organization, operations, and cross-functional teamwork ✔ Thrives in a fast-paced startup environment 👉 Apply here: https://lnkd.in/esre36Ar Know someone who might be a fit? Tag them below! #biotechjobs #medicalaffairs #operations #hiring #Veradermics

Pattern hair loss is the largest aesthetics condition worldwide -- yet innovation has lagged, leaving people underserved and clinicians without the tools they need to deliver transformative care.  It’s time for progress in pattern hair loss. At Veradermics, we’re focused on advancing potentially the first non-hormonal oral therapeutic for hair regrowth in women and men.   Learn more about our lead investigational candidate in pattern hair loss:  bit.ly/3WsyFJA #androgeneticalopecia #patternhairloss #aesthetics #dermatology 

In pattern hair loss, too many patients and providers have been left with false hope and half-answers. Our CEO, dermatologist Reid Waldman, has seen the distress this causes first-hand in practice - and that’s why he’s so intent on working hard to change the standard of care.    Learn more about pattern hair loss: bit.ly/47sZtjd   #androgeneticalopecia #patternhairloss #aesthetics #dermatology

At Veradermics, we’re working on a solution for pattern hair loss.    Pattern hair loss affects 80 million people in the United States, and it's been nearly three decades with no new prescription therapies for men –- and for women, an oral treatment option has never existed.    Learn more about our lead investigational candidate in pattern hair loss: bit.ly/3WsyFJA     #patternhairloss #androgeneticalopecia #innovation #aesthetics #dermatology 

We’re building the next chapter at Veradermics — and we’re hiring. 🚀    Yesterday’s Series C announcement was a major milestone — but it’s only the beginning. With $150 million in new funding and encouraging Phase 2 data for VDPHL01, our potential first-in-class non-hormonal oral therapeutic for hair regrowth, we’re expanding our team across functions to fuel this next phase of growth. If you’re passionate about translating breakthrough science into meaningful patient impact, we’d love to meet you. 🔬 Current openings:  VP, Medical Affairs Medical Science Liaison (West Coast, East Coast, Central US, Southern US) …and more roles coming soon. Explore opportunities to join our mission: https://lnkd.in/e4ar8zFX   Read yesterday’s announcement: http://bit.ly/4os8KO9  #Veradermics #DermatologyInnovation #SeriesC #BiotechCareers #MedicalAffairs #ClinicalDevelopment 

Today marks a significant milestone for the Veradermics team: we are excited to announce the completion of an oversubscribed $150M Series C financing round to advance our lead investigational candidate, VDPHL01, as the potentially first non-hormonal oral therapeutic option for hair regrowth in both women and men. This news is accompanied by encouraging preliminary phase 2 data in males. Pattern hair loss, or Androgenetic Alopecia, is one of the largest aesthetics conditions worldwide, yet there have been no new approved prescription therapies in nearly 30 years. We’re excited about the potential to change the landscape for good, and look forward to sharing more progress.    Learn more: http://bit.ly/4os8KO9 #androgeneticalopecia #biopharmaceutical #dermatology #aesthetics #financing #patternhairloss #hairloss

🚨 We’re Hiring! 🚨 Veradermics is searching for a Medical Science Liaison (MSL) to expand our field medical presence and support our dermatology pipeline. This role will build strong relationships with key opinion leaders, translate science into clinical impact, and ensure alignment across research and practice. Ideal for someone who thrives on scientific exchange, enjoys building trusted partnerships with HCPs, and is excited by the chance to shape the future of aesthetics and dermatology. 📍 Field-based – Nevada or Arizona  🧳 ~60% travel across the West Coast territory 📄 Learn more: Job description below 📩 Referrals welcome – send to kristen@greenlinetalentgroup.com Join us in advancing next-generation treatments in dermatology! #hiring #MSL #medicalscienceliaison #biotechjobs #dermatology #fieldmedical   https://lnkd.in/e2W7MM2Z 

🎉 Veradermics is hiring a Director, Financial Planning & Analysis! 🎉 This is a great opportunity for someone who wants to:  🔹 Build and shape the FP&A function at a growing biotech 🔹 Partner with R&D and clinical leaders on forecasting and cash runway  🔹 Be hands-on as a sole contributor to start, with room to grow If you know a strong FP&A leader tag them below or submit a referral through the application link. https://lnkd.in/gEA39eGd

🚨 We’re Hiring! 🚨 Veradermics is searching for an Investor Relations & Corporate Project Manager to drive the execution of high-impact investor and corporate project initiatives. This hybrid role partners closely with the CFO and CEO to manage IR and comms vendors, prep for investor meetings, and ensure all messaging is sharp, timely, and strategically aligned. Ideal for someone who thrives in fast-paced, investor-sensitive environments and loves translating strategy into polished deliverables and tightly run workstreams. 📍 Hybrid – New Haven, CT 🧳 ~30% travel to key investor events 📄 Learn more: Job description below 📩 Referrals welcome – send to kristen@greenlinetalentgroup.com Join us in shaping the future of aesthetics and dermatology! #hiring #biotechjobs #biotechcareers #ctbiotech #projectmanagement #investorrelations https://lnkd.in/dHuMB6hr